GYNecological Cancers Treated with NETrin MAbs in Combination with Chemotherapy and /or Pembrolizumab
Clinical trial NCT04652076 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04652076
- Sponsor
- NETRIS Pharma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-12-14
- Primary completion
- 2025-10-30
- Enrollment
- 240
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.